Home Genome Editing Gene Therapy

Gene Therapy

    Most popular
    Gene Therapy

    GenVec and Novartis Cement Hearing Loss Partnership with Manufacturing Deal

    Gene Therapy

    Oxford BioMedica, Bioverativ to Develop Lentiviral Vectors for Hemophilia Gene Therapy

    Gene Therapy

    Unlocking the Potential of CRISPR-Based Gene Editing

    Gene Therapy

    Miltenyi Acquires Gene Therapy Assets from Lentigen

    This image shows an array of nanospears before being released for delivery of genetic information to cells. [UCLA Broad Stem Cell Research Center/ACS Nano]
    Gene Therapy

    Nanospears May Revolutionize Gene Therapy

    Gene Therapy

    Sangamo, Pfizer Partner on Gene Therapy for ALS, FTLD

    Astellas Pharma sees potential in Quethera's gene therapy program
    Gene Therapy

    Astellas Expands Its Eye Disorder Pipeline with Quethera Purchase

    The Cell and Gene Therapy (CGT) Catapult will partner with Freeline Therapeutics to build the gene therapy developer's proprietary manufacturing platform at the CGT Catapult’s large-scale GMP manufacturing center in Stevenage
    Gene Therapy

    U.K.’s CGT Catapult Partners with Freeline to Build Gene Therapy Manufacturing...

    Benitec Biopharma could generate up to $655 million-plus in payments from licensing its preclinical gene therapy for oculopharyngeal muscular dystrophy (OPMD; pictured)
    Gene Therapy

    Axovant Licenses Benitec Gene Therapy Candidates for OPMD, Neurological Disorders

    A multifunctional vehicle for tumor therapy based on the delivery of Cas9-sgPlk-1 plasmids has been developed. This AuNP (gold nanoparticle)-condensed
    Gene Therapy

    Nonviral Gene Therapy Platform Delivers CRISPR/Cas9 to Tumors

    123...47Page 1 of 47
    Copyright © 2022 Genetic Engineering & Biotechnology News. All Rights Reserved.